Breast cancer clinical outcomes and tumor immune microenvironment: cross-dialogue of multiple epigenetic modification profiles
Aging · 2024
DOI: 10.18632/aging.205853 ↗Kurz gefasst
Fachartikel in der Zeitschrift Aging, 2024. Verfasst von Chong Teng und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Oncology, The Second Affiliated Hospital of Harbin Medical University, Harbin, Heilongjiang, China. Hauptthemen laut MEDLINE: Breast Neoplasms, Tumor Microenvironment, Epigenesis, Genetic, Gene Expression Regulation, Neoplastic. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 56 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Oncology, The Second Affiliated Hospital of Harbin Medical University, Harbin, Heilongjiang, China.
- Oncology, Harbin Medical University, Harbin, Heilongjiang, China.
- School of Nursing, Harbin Medical University, Harbin, Heilongjiang, China.
Zitieren
APA
Teng, C., Song, X., Fan, C., Man, S., Hu, Y., Hou, Y., & Xin, T. (2024). Breast cancer clinical outcomes and tumor immune microenvironment: cross-dialogue of multiple epigenetic modification profiles. Aging. https://doi.org/10.18632/aging.205853
Vancouver
Teng C, Song X, Fan C, Man S, Hu Y, Hou Y, et al. Breast cancer clinical outcomes and tumor immune microenvironment: cross-dialogue of multiple epigenetic modification profiles. Aging. 2024. doi:10.18632/aging.205853
BibTeX
@article{Teng2024,
author = {Teng, Chong and Song, Xiaowei and Fan, Chengjuan and Man, Siqi and Hu, Yuanyuan and Hou, Yifei and Xin, Tao},
title = {Breast cancer clinical outcomes and tumor immune microenvironment: cross-dialogue of multiple epigenetic modification profiles},
journal = {Aging},
year = {2024},
doi = {10.18632/aging.205853}
}
EUVIMED